The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Connectivity

[1]  M. Geyer,et al.  Effects of MDMA (Ecstasy) on Prepulse Inhibition and Habituation of Startle in Humans after Pretreatment with Citalopram, Haloperidol, or Ketanserin , 2001, Neuropsychopharmacology.

[2]  Nicolas Costes,et al.  A 18F-MPPF PET normative database of 5-HT1A receptor binding in men and women over aging. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  F. Vollenweider,et al.  Psychological and Physiological Effects of MDMA (“Ecstasy”) after Pretreatment with the 5-HT2 Antagonist Ketanserin in Healthy Humans , 2000, Neuropsychopharmacology.

[4]  Distribution of serotonin-1A receptors in the monkey and the postmortem human hippocampal region. A quantitative autoradiographic study using the selective agonist [3H]8-OH-DPAT , 1986, Neuroscience Letters.

[5]  Katarina Varnäs,et al.  Autoradiographic mapping of 5-HT1B and 5-HT1D receptors in the post mortem human brain using [3H]GR 125743 , 2001, Brain Research.

[6]  F. Tretter.  [Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?]. , 1997, Der Nervenarzt.

[7]  M. Liechti,et al.  MDMA enhances “mind reading” of positive emotions and impairs “mind reading” of negative emotions , 2012, Psychopharmacology.

[8]  F. Vollenweider,et al.  Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA , 2009, Journal of psychopharmacology.

[9]  R. Lanius,et al.  Emotion modulation in PTSD: Clinical and neurobiological evidence for a dissociative subtype. , 2010, The American journal of psychiatry.

[10]  M. Liechti,et al.  Effects of the α2-Adrenergic Agonist Clonidine on the Pharmacodynamics and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Healthy Volunteers , 2012, Journal of Pharmacology and Experimental Therapeutics.

[11]  M. Wilson,et al.  The organization of serotonergic projections to cerebral cortex in primates: Regional distribution of axon terminals , 1991, Neuroscience.

[12]  G H Glover,et al.  Image‐based method for retrospective correction of physiological motion effects in fMRI: RETROICOR , 2000, Magnetic resonance in medicine.

[13]  F. Vollenweider,et al.  Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors , 2012, Biological Psychiatry.

[14]  J. Palermo-neto,et al.  Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice. , 2011, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[15]  C. Sripada,et al.  Altered resting-state amygdala functional connectivity in men with posttraumatic stress disorder. , 2012, Journal of psychiatry & neuroscience : JPN.

[16]  Mihir A. Topiwala,et al.  Synchronized Activity between the Ventral Hippocampus and the Medial Prefrontal Cortex during Anxiety , 2010, Neuron.

[17]  Sylvain Houle,et al.  Neuromodulation of frontal and temporal cortex by intravenous d-fenfluramine: an [15O]H2O PET study in humans , 1996, Neuroscience Letters.

[18]  M. Liechti,et al.  Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex , 2012, Psychopharmacology.

[19]  T. Brewerton,et al.  Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study , 2013, Journal of psychopharmacology.

[20]  T. Reader,et al.  Distribution of monoamines and metabolites in rabbit neostriatum, hippocampus and cortex , 1989, Brain Research Bulletin.

[21]  Karl J. Friston,et al.  Analysing connectivity with Granger causality and dynamic causal modelling , 2013, Current Opinion in Neurobiology.

[22]  S. Krähenbühl,et al.  Duloxetine Inhibits Effects of MDMA (“Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study , 2012, PloS one.

[23]  I. McGregor,et al.  MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635 , 2011, Brain Research Bulletin.

[24]  M. Liechti,et al.  &agr;1-Adrenergic Receptors Contribute to the Acute Effects of 3,4-Methylenedioxymethamphetamine in Humans , 2013, Journal of clinical psychopharmacology.

[25]  G. Edwards.  Ecstasy: The Complete Guide. A Comprehensive Look at the Risks and Benefits of MDMA , 2002 .

[26]  J. Detre,et al.  Perfusion magnetic resonance imaging with continuous arterial spin labeling: methods and clinical applications in the central nervous system. , 1999, European journal of radiology.

[27]  J. Guérit,et al.  The temporal lobe and the limbic system, P. Gloor (Ed.). Oxford University Press (1997), 865 , 2000 .

[28]  M. Fox,et al.  Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging , 2007, Nature Reviews Neuroscience.

[29]  B. Biswal,et al.  Functional connectivity in the motor cortex of resting human brain using echo‐planar mri , 1995, Magnetic resonance in medicine.

[30]  K. Rice,et al.  Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin , 2001, Synapse.

[31]  I. McGregor,et al.  Neural correlates of MDMA (“Ecstasy”)-induced social interaction in rats , 2009, Social neuroscience.

[32]  M. Donzelli,et al.  Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans , 2012, British journal of pharmacology.

[33]  Victor W Pike,et al.  5‐HT radioligands for human brain imaging with PET and SPECT , 2013, Medicinal research reviews.

[34]  D. E. Nichols,et al.  Effects of Schedule I drug laws on neuroscience research and treatment innovation , 2013, Nature Reviews Neuroscience.

[35]  M. Angstadt,et al.  Effects of MDMA on sociability and neural response to social threat and social reward , 2009, Psychopharmacology.

[36]  C. de Montigny,et al.  Effect of Pindolol on the Function of Pre- and Postsynaptic 5-HT1A Receptors: In Vivo Microdialysis and Electrophysiological Studies in the Rat Brain , 1996, Neuropsychopharmacology.

[37]  Harriet de Wit,et al.  Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others , 2010, Biological Psychiatry.

[38]  C. Halldin,et al.  Quantitative Analysis of [11C]AZ10419369 Binding to 5-HT1B Receptors in Human Brain , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  Jan K. Buitelaar,et al.  Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol) , 2010, Psychopharmacology.

[40]  J. Jonides,et al.  Depression, rumination and the default network. , 2011, Social cognitive and affective neuroscience.

[41]  L. Jerome,et al.  The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study , 2011, Journal of psychopharmacology.

[42]  C. Frith.  Social Cognition: Hi There! Here's Something Interesting , 2008, Current Biology.

[43]  R. Hen,et al.  The serotonergic system and anxiety , 2007, NeuroMolecular Medicine.

[44]  Rodrigo Andrade,et al.  Serotonergic regulation of neuronal excitability in the prefrontal cortex , 2011, Neuropharmacology.

[45]  F. Vollenweider,et al.  Effects of a β-blocker on the cardiovascular response to MDMA (Ecstasy) , 2010, Emergency Medicine Journal.

[46]  W. M. Bosker,et al.  Effects of Acute MDMA Intoxication on Mood and Impulsivity: Role of the 5-HT2 and 5-HT1 Receptors , 2012, PloS one.

[47]  J. Mazziotta,et al.  Modulating emotional responses: effects of a neocortical network on the limbic system , 2000, Neuroreport.

[48]  F. Vollenweider,et al.  Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers , 1998, Neuropsychopharmacology.

[49]  Timothy Edward John Behrens,et al.  A Tractography Analysis of Two Deep Brain Stimulation White Matter Targets for Depression , 2009, Biological Psychiatry.

[50]  C. Frith,et al.  Rapid Response Subject Collections , 2022 .

[51]  E. Formisano,et al.  MDMA intoxication and verbal memory performance: a placebo-controlled pharmaco-MRI study , 2011, Journal of psychopharmacology.

[52]  Olaf B. Paulson,et al.  Brain serotonin 2A receptor binding: Relations to body mass index, tobacco and alcohol use , 2009, NeuroImage.

[53]  P. Whalen,et al.  The structural and functional connectivity of the amygdala: From normal emotion to pathological anxiety , 2011, Behavioural Brain Research.

[54]  Katarina Varnäs,et al.  Distribution of 5-HT7 receptors in the human brain: a preliminary autoradiographic study using [ 3 H ]SB-269970 , 2004, Neuroscience Letters.

[55]  E. Formisano,et al.  Involvement of Inferior Parietal Lobules in Prospective Memory Impairment during Acute MDMA (Ecstasy) Intoxication: An Event-Related fMRI Study , 2009, Neuropsychopharmacology.

[56]  W. M. Bosker,et al.  Blockade of 5-HT2 Receptor Selectively Prevents MDMA-Induced Verbal Memory Impairment , 2011, Neuropsychopharmacology.

[57]  J. Palacios,et al.  Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites , 1986, Brain Research.

[58]  F. Vollenweider,et al.  Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies , 2001, Human psychopharmacology.

[59]  M. Liechti,et al.  The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (“Ecstasy”) in Humans , 2011, Clinical pharmacology and therapeutics.

[60]  Richard G. Wise,et al.  Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin , 2012, Proceedings of the National Academy of Sciences.

[61]  P. Celada,et al.  How does pindolol improve antidepressant action? , 2001, Trends in pharmacological sciences.

[62]  F. Vollenweider,et al.  3,4-Methylenedioxymethamphetamine (MDMA) Modulates Cortical and Limbic Brain Activity as Measured by [H215O]-PET in Healthy Humans , 2000, Neuropsychopharmacology.

[63]  R. de la Torre,et al.  Non-linear pharmacokinetics of MDMA ('ecstasy') in humans. , 2000, British journal of clinical pharmacology.

[64]  F. Vollenweider,et al.  Localization of MDMA‐induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA) , 2001, Human brain mapping.

[65]  S. Borgwardt,et al.  Reduction in Cerebral Perfusion after Heroin Administration: A Resting State Arterial Spin Labeling Study , 2013, PloS one.

[66]  R. Lanius,et al.  THE DISSOCIATIVE SUBTYPE OF POSTTRAUMATIC STRESS DISORDER: RATIONALE, CLINICAL AND NEUROBIOLOGICAL EVIDENCE, AND IMPLICATIONS , 2012, Depression and anxiety.

[67]  J. Mendelson,et al.  Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans , 2002, Psychopharmacology.

[68]  G. Ricaurte,et al.  Acquisition of MDMA self‐administration: pharmacokinetic factors and MDMA‐induced serotonin release , 2014, Addiction biology.

[69]  A. Grace,et al.  The Prefrontal Cortex Regulates Lateral Amygdala Neuronal Plasticity and Responses to Previously Conditioned Stimuli , 2003, The Journal of Neuroscience.

[70]  Christoph Mulert,et al.  Neuroimaging in anxiety disorders , 2011, Dialogues in clinical neuroscience.